学术探索
学术期刊
新闻热点
数据分析
智能评审

PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS

被引：357
作者：
ERICE, A
CHOU, S
BIRON, KK
STANAT, SC
BALFOUR, HH
JORDAN, MC
机构：
[1] UNIV MINNESOTA,HLTH SCI CTR,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,HLTH SCI CTR,DEPT PEDIAT,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,HLTH SCI CTR,DEPT MED,MINNEAPOLIS,MN 55455
[4] UNIV MINNESOTA,HLTH SCI CTR,DEPT MICROBIOL,MINNEAPOLIS,MN 55455
[5] OREGON HLTH SCI UNIV,DIV INFECT DIS,PORTLAND,OR 97201
[6] BURROUGHS WELLCOME CO,DEPT VIROL,RES TRIANGLE PK,NC 27709
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1989年 / 320卷 / 05期
关键词：
D O I：
10.1056/NEJM198902023200505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 293
页数：5
相关论文
共 35 条
  • [1] 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE FOR CYTOMEGALO-VIRUS INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    BACH, MC
    BAGWELL, SP
    KNAPP, NP
    DAVIS, KM
    HEDSTROM, PS
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) : 381 - 382
  • [2] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE
    BIRON, KK
    FYFE, JA
    STANAT, SC
    LESLIE, LK
    SORRELL, JB
    LAMBE, CU
    COEN, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773
  • [3] METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS
    BIRON, KK
    STANAT, SC
    SORRELL, JB
    FYFE, JA
    KELLER, PM
    LAMBE, CU
    NELSON, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) : 2473 - 2477
  • [4] 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    CHACHOUA, A
    DIETERICH, D
    KRASINSKI, K
    GREENE, J
    LAUBENSTEIN, L
    WERNZ, J
    BUHLES, W
    KORETZ, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) : 133 - 137
  • [5] ACQUISITION OF DONOR STRAINS OF CYTOMEGALOVIRUS BY RENAL-TRANSPLANT RECIPIENTS
    CHOU, SW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (22) : 1418 - 1423
  • [6] INVITRO SUSCEPTIBILITY OF CYTOMEGALOVIRUS ISOLATES FROM IMMUNOCOMPROMISED PATIENTS TO ACYCLOVIR AND GANCICLOVIR
    COLE, NL
    BALFOUR, HH
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (03) : 255 - 261
  • [7] MULTIPLE INFECTIONS BY CYTOMEGALOVIRUS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME - DOCUMENTATION BY SOUTHERN BLOT HYBRIDIZATION
    DREW, WL
    SWEET, ES
    MINER, RC
    MOCARSKI, ES
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (06) : 952 - 953
  • [8] GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS
    ERICE, A
    JORDAN, C
    CHACE, BA
    FLETCHER, C
    CHINNOCK, BJ
    BALFOUR, HH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22): : 3082 - 3087
  • [9] TREATMENT OF CYTOMEGALO-VIRUS RETINITIS WITH 9-[2-HYDROXY-1-(HYDROXYMETHYL)ETHOXYMETHYL]GUANINE
    FELSENSTEIN, D
    DAMICO, DJ
    HIRSCH, MS
    NEUMEYER, DA
    CEDERBERG, DM
    DEMIRANDA, P
    SCHOOLEY, RT
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) : 377 - 380
  • [10] HUMAN PHARMACOKINETICS OF THE ANTIVIRAL DRUG DHPG
    FLETCHER, C
    SAWCHUK, R
    CHINNOCK, B
    DEMIRANDA, P
    BALFOUR, HH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) : 281 - 286
1234